APPLICATION OF CYCLOSPORINE AND PEGYLATED INTERFERON COMBINATION FOR HEPATITIS (HCV) TREATMENT

摘要

FIELD: medicine.;SUBSTANCE: invention relates to medicine, in particular to gastroenterology, and deals with application of conjugate of interferon with water-soluble polymer in combination with ribavirin and cyclosporine A for preparation of medication intended for treatment of HCV-induced infection. Invention ensures efficient impact in patients with HCV infection who initially did not respond to monotherapy with pegylated interferon, as well as combination of interferon A with ribavirin or interferon with cyclosporin A.;EFFECT: claimed method of application of cyclosporine and pagylated interferon combination.;14 cl